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Available online 18 January 2014Camel antibodies have been widely investigated, but work has focused upon the unique
heavy chain antibodies found across camelid species. These are homodimers, devoid of light
chains and the first constant heavy chain domain. Camelid species also display conventional
hetero-tetrameric antibodies with identical pairs of heavy and light chains; in Camelus
dromedarius these constitute 25% of circulating antibodies. Few investigations have been
made on this subset of antibodies and complete conventional camel IgG sequences have not
been reported.
Here we study the sequence diversity of functional variable and constant regions observed in
57 conventional heavy, 18 kappa and 35 lambda light chains of C. dromedarius and Camelus
bactrianus. We detail sequences of the full kappa and lambda light chain, variable and CH1
region for IgG1a and IgG1b and the CH2 and CH3 region for IgG1a. The majority (60%) of IgG1
variable region sequences aligned with the human IgHV3 family (clan III) and had leader
sequences beginning with MELG whereas the remaining sequences aligned with the IgHV4
(clan II) and had leader sequences beginning with MRLL. Distinct differences in CDR length
were observed between the two; where CDR1 was typically 5 and 7 residues and CDR2 at 17
and 16 residues, respectively. CDR3 length of IgHV4 (range 11 to 20) was closer to that typical
of VHH antibodies than that of IgHV3 (range 3 to 18 residues). Designed oligonucleotide
primers have enabled identification of paired heavy and light chains of conventional camel
antibodies from individual B cell clones.
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The hetero-tetrameric heavy and light chain IgG antibody
format formed the central dogma for antibody structure until
1993 when a novel antibody structure was discovered in the
camelid species Camelus dromedarius (Hamers-Casterman et
al., 1993). These novel antibodies, termed heavy chain anti-
bodies (HCAbs), were shown to be heavy chain homodimers,
which did not associate with a light chain, and lacked the
CH1 domain (Muyldermans et al., 1994; Nguyen et al., 1999).
Immunological investigation of all members of the Camelidae
family has shown the co-existence of conventional and heavy
chain antibodies (Hamers-Casterman et al., 1993; Maass et al.,
2007; Van der Linden et al., 2000). In camels, heavy chain
antibodies constitute 75% of circulating antibodies (Hamers-
Casterman et al., 1993). To distinguish them from conventional
antibody heavy chain variable regions (VH), the variable
domain of heavy chain antibodies has been denoted VHH. The
unique structure and novel characteristics of this new class of
antibodies are of commercial significance with VHH fragments
(known as nanobodies) forming a new class of therapeutics
used to treat human diseases (Muyldermans et al., 2009). The
extended CDR-H3 region characteristic of VHH fragments, and
their preference for binding protein clefts, makes them an
interesting tool in the pharmaceutical industry (Lawson, 2012).
Since their discovery, considerable research has been
undertaken to understand the evolution, sequence diversity
and biophysical characteristics of the novel heavy chain
antibodies. A wealth of sequence information is available for
this novel subset of antibodies, however considerably fewer
investigations have been made into the sequence diversity of
conventional camel antibodies. Comparisons have been made
of VHH and VH region sequences (Vu et al., 1997; Harmsen
et al., 2000; Nguyen et al., 1998; Nguyen et al., 2000) and
numerous publications document camel conventional anti-
body hinge sequences. However, assessment of the full
constant region sequences for IgG1a and IgG1b is lacking, with
only a single publication providing nucleotide sequence infor-
mation for an IgG1 constant region, from anon-rearranged llama
genomic DNA library (Woolven et al., 1999). In addition to a
paucity of conventional heavy chain data, a complete lack of
light chain data exists. Although reference has been made to
camel light chain sequence investigations (Legssyer et al., 1995;
De Genst et al., 2006), no publication of the data has been
identified. The complete sequencing of the C. dromedarius
genome is underway (Al-Swailem et al., 2010) and inspection
of deposited expressed sequence tag data indicates that there
are 5 lambda constant region genes and only one kappa
constant region gene (http://camel.kacst.edu.sa/). Similarly a
draft genome of wild and domesticated Bactrian camels has
recently been reported (Jirimutu et al., 2012).
The existence of two structurally distinct types of antibody
variable regions in camelids offers the opportunity to compare
structure and functional relationships of VHHand conventional
combining sites resulting from an immune response to a
defined antigen. As a necessary prelude to such a study, here
we characterize heavy and light chain sequence diversity of
dromedary and Bactrian IgG1utilizing RACE technology. This
has allowed design of oligonucleotide primers that enable the
identification of paired heavy and light chain sequences from
individual camel B cells.2. Materials and methods
2.1. Source material
PBMCswere sourced from ten dromedary and two Bactrian
out-bred camelsmaintained at the Central Veterinary Research
Laboratory (CVRL) Dubai. The camels had not been purposely
immunized for this study. Blood sampling was performed
according to a humane protocol approved by the Scientific
Directorate of the CVRL.
2.2. PBMC mRNA extraction
To remove non-viable cells, PBMCwere cultured overnight in
RPMI media (10% FCS, 2 mM glutamine, 20 mM HEPES, 55 nM
2-mercaptoethanol, 100 U/ml penicillin, 100 ug/ml streptomy-
cin). RNAwas extracted fromapproximately 5 × 106 PBMC from
individual camels using Qiagen RNEasy kits, according to the
manufacturer's instructions. RNA was stored at−80 °C.
2.3. Heavy and light chain cDNA preparation
RACE-ready cDNA templates, both 5′ and 3′, were prepared
for each RNA sample, as detailed in the SMART RACE protocol
(BD Biosciences). Dromedary and Bactrian pools of cDNAwere
prepared, with the amount of cDNA added to each pool
standardized according to the initial cell number from which
the RNA was derived.
Antisense oligonucleotides CALL002 (GGTACGTGCTGTTGA
ACTGTTCC) (Conrath et al., 2001) and CH2FORTA4 (CGCCATC
AAGGTACCAGTTGA) (Ghahroudi et al., 1997), which annealed in
the CH2 region, were employed in the heavy chain 5′ RACE PCR
reaction. To assess sequence variability in the heavy chain Fc
region a heavy chain 3′ RACE PCR reaction was undertaken
utilizing individual hinge region specific sense oligonucleotides
(1a: CAACCACAACCAGGATGCACG, 1b: GAACCGCATGGAGGATG
CCCG). These oligonucleotides were designed for each isotype
based upon sequence information gained in the heavy chain 5′
RACE experiment.
Due to the absence of published camel light chain sequences,
an initial kappa light chain 5′ RACE PCR reaction was conducted
using a non-camel specific oligonucleotide (CTGCTCAVTGGAT
GGTGGGAAGA) designed based upon an alignment of homol-
ogous regions of the kappa light chain constant domains of
human, rabbit and mouse sequences. Sequence analysis of the
resultant PCR product isolated two camel kappa light chain
sequences. These sequences were used to re-design a camel-
specific framework 3 oligonucleotide (GCTGATCGTGAGAGTGA
AATC, antisense) and a leader sequence specific oligonucleotide
(ATGGGGCCACAGCCACGCCTGCTCAC, sense) for use in the 5′
and 3′ camel kappa light chain RACE experiments respectively.
Lambda light chain 3′ RACE investigations were undertaken
using a documented sense oligonucleotide (GCCGGCCATGGCCT
GGGCTCTGCTCC) (Conrath et al., 2005).
All RACE PCR reactions were undertaken as defined in the
SMART RACE protocol, using oligonucleotides detailed above
and KOD hot start polymerase. RACE PCR products were
analyzed by gel electrophoresis. 5′ heavy chain RACE PCR
products were observed to migrate in a triple banding pattern.
The largest bandwas predicted to represent conventional heavy
chain antibodies (IgG1a and IgG1b); the two smaller bands
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short hinged heavy chain-only antibodies (IgG2c or IgG3).
Single bands of the expected molecular weight were observed
for the heavy chain 3′ RACE and light chain RACE reactions.2.4. Sequence analysis
All bands were cloned into the pCR blunt II TOPO vector
(Invitrogen). To improve sequencing accuracy, sequencing in
both 5′ and 3′ directions was performed using M13F and T3
primers (Invitrogen) and with PCR oligonucleotides. Heavy
chain 5′ and 3′ RACE experiments on the same pooled mRNA
material were designed to produce sequence overlap between
the two experiments to allow inference of a contiguous reading
sequence between leader, variable, CH1 and hinge region
sequences isolated in the 5′ heavy chain RACE experiment and
the CH2 and CH3 region sequences isolated from the 3′ heavy
chain RACE. The 3′ light chain RACE experiments were designed
such that they primed from the leader sequence through to the
end of the light chain constant domain, thus the light chain
sequence data was generated from a single mRNA strand.
Sampleswere analyzed on a 3100 automatedDNA sequencer
(Applied Biosystems). Phylogenetic treeswere constructedusing
vector NTI software (Invitrogen).2.5. Accession numbers
All sequences described in this study have been deposited
with the European Molecular Biology Laboratory Nucleotide
Sequence Database, http://www.ebi.ac.uk/ena/, (accession
numbers: HE653038 to HE653115 and HF952172 to
HF952206).3. Results and discussion
3.1. Identiﬁcation of IgG1 isotypes
Investigation of the VH repertoire of dromedary and
Bactrian camels was enabled using CH2 specific antisense
primers in a 5′ RACE experiment on respective pooled cDNA
from the two species. Sequencing of plasmid clones derived
from gel purified bands running at approximately 1050 bp,
revealed over 50 unique IgG1 sequences (30 dromedary and
27 Bactrian) after elimination of duplicates and incomplete
sequences. High sequence identity, present in the hinge
region, was used to delineate sequences into 23 IgG1a (Figs.
S1 & S2) and 34 IgG1b (Figs. S3 & S4) isotypes. The IgG1
sequences displayed the expected antibody arrangement
whereby the variable region was followed by a CH1 domain
and a hinge region. The presence of a CH1 domain, and
the similarity of the hinge sequences with previously docu-
mented hinge sequences (Vu et al., 1997), indicate that these
camel sequences have the characteristics of conventional
antibodies. With one exception (Fig. S3, sequence D75), the
sequences all lack the hallmark substitutions (Val37Phe/Tyr,
Gly44Glu, Leu45Arg, Trp47Gly/Leu) associated with camelid
VHH framework 2 region, and as such would be expected to
associate with a light chain.3.2. Heavy chain variable region sequences
Two leader sequences were observed in the isolated IgG1
sequences (Figs. S1 & S3). The established leader sequence
commonly associated with camel VH and VHH genes, MELG
LSWVVLAALLQGVQA (MELG) (Nguyen et al., 1998) and a
recently identified leader sequence, MRLLGLLLCLVAGPQGVLS
(MRLL) (Deschacht et al., 2010). Each leader sequence was
observed in the IgG1a and IgG1b isotypes of both dromedary
and Bactrian species. Genomic analysis, using IgBlast (www.
ncbi.nlm.nih.gov/igblast) and ImMunoGeneTics (www.imgt.
org), showed that V-regions downstream of the MELG leader
sequence belong to the human IgHV3 family of clan III, while the
MRLL leader sequence is associated with V-regions belonging to
the IgHV4 family of clan II, supporting the previous findings
(Deschacht et al., 2010). At the nucleotide level 34 unique leader
sequences were identified (18 dromedary, 16 Bactrian). Since
this region is presumably not under somatic mutation pressure
to generate binding site diversity, the number of leader
sequences found may give an estimate of V-gene usage.
Genomic analysis of the dromedary (http://camel.kacst.edu.
sa/) indicates that there are 129 heavy variable region genes,
VH(88) and VHH(41) genes, so the present study suggests
that at least 20% of VH genes were transcriptionally active in
the dromedary. Jirimutu et al. (2012) report 17 heavy chain
variable region genes in the Bactrian, thus variable gene usage
in this species may be relatively higher.
Separate framework region consensus sequences were
constructed according to the leader sequence used, the species
and the IgG1 isotype (Fig. 1a). Irrespective of the species or
isotype, highest sequence identity was observed when the
framework consensus sequences were aligned according to
leader sequence: for the MELG leader, the VH(3) family had a
93% sequence identity and for the MRLL leader, the VH(4)
family had a 92% sequence identity of framework consensus
sequences. For each leader type, the high framework sequence
similarity observed between the dromedary and Bactrian, is
indicative of V-region gene conservation across the two
species. Conversely framework sequences between the VH(3)
and VH(4) families had only 60–62% identity.
Vu et al. (1997) report close similarity between llama and
human VH sequences; these are shown in Fig. 1a, aligned
against respective camel framework sequences. Inspection
reveals a 100% sequence identity between camel VH(3)
consensus and llama framework residues (six published llama
sequences but with residues 1 to 8 missing) and a 94% identity
between camel VH(3) consensus and human consensus
framework sequences with only four conservative differences
at residues 49, 74, 83 and 84. Identity between camel VH(4)
consensus and human consensus framework sequences is
lower at 86%. Phylogenetic analysis between consensus frame-
work regions of various mammalian immunoglobulin se-
quences (Fig. 2a) shows that dromedary and Bactrian VH(3)
sequences cluster closest to human clan III; whereas drome-
dary and Bactrian VH(4) sequences cluster with clan II
sequences, human VH(2) and murine VH(2) and VH(3).
Interestingly the framework consensus sequence of VH(4)
was almost identical to that reported for llamaVH(4) (Deschacht
et al., 2010), the latter having a bias towards threonine over
serine at position 79 (Fig. 1a). These authors provide compelling
evidence that in dromedary and llama species, VH(4), D
ab
Fig. 1. a) Alignment of consensus IgG1a and IgG1b variable region framework sequences for dromedary and Bactrian species compared to corresponding llama
and human consensus sequences. Sequences are grouped according to dromedary (D), Bactrian (B) and the leader sequence used. Identical residues are displayed
as ‘−’, variable residues displayed as ‘X’. Differences observed between the VH(3) and VH(4) sequences are highlighted in gray. Human and llama sequences were
extracted from the IMGT database (http://www.imgt.org).b) Positional variability of VH, VK and VL framework regions. The percentage of positions within each
framework, where residues differ from consensus sequence, is shown for each isotype and variable gene family.
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both conventional andHCAb constant regions to give functioning
antibodies. In the latter case, antigen binding was demonstratedin the absence of a light chain; in the former case the require-
ment of a light chainmay be optional or target dependent. Based
on the present study,where theVH(4) familywas represented in
39L.M. Grifﬁn et al. / Journal of Immunological Methods 405 (2014) 35–4640% of the isolated conventional heavy chain sequences in both
dromedary and Bactrian camels, onemay assume that the above
recombination events may play a significant role in generating
immune response diversity in these species.Fig. 2. Dendrograms showing the phylogenetic relationship between dromedary a
sequences and corresponding regions from other mammalian species. The phylogen
The figures in parentheses relate to the degree of divergence between the sequences
al. (1991). Consensus sequences for human, mouse, rat, rabbit, llama and pig wereAntibody diversity is further increased by somatic hyper
mutation of the variable region genes; particularly in CDR loops
but also in framework regions (Tonegawa, 1983). Positional
variability in framework regions is summarized in Fig. 1b; itnd Bactrian variable region of a) heavy chain and b) light chain framework
etic tree is based on the Neighbor Joining method of Saitou and Nei (1987).
. Shaded boxes denote sequences clustered into clans according to Kirkham et
extracted from the IMGT database (http://www.imgt.org).
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Fig. 4. Alignment of camel IgG1 CH1 and hinge region sequences with human and mouse IgG1. Camel IgG1a and IgG1b from this study are compared with human
and mouse IgG1 taken from the IMGT database (http://www.imgt.org). Identical residues are displayed as ‘−’ and spaces are inserted to optimize the alignment.
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2. Variability was consistently greater in VH(3) framework
compared to VH(4) framework; this may reflect a combination
of differential VH germ-line gene usage and a preference for
VH(3) over VH(4) as the immune response matures. Greater
variability of framework regions in IgG1b isotypes compared to
IgG1a isotypes may be explained by an isotype switch with
immune response maturation.3.3. Heavy chain CDR length
Variability in CDR length is detailed in Fig. 3, where dif-
ferences between VH(3) and VH(4) sequences are compared
according to the Kabat et al. (1991) definition. The CDR-H1 in
all 34 VH(3) sequences was consistently 5 residues whereas
the length of VH(4) was 7 residues with one exception at 6
residues. A slightly different picture emerges using the IMGT
CDR definition (Lefranc et al. 2003) as indicated in Supple-
mentary data, S1 and S3; while VH(4) sequences had the
corresponding 10 or 9 residues, VH(3) had the corresponding
8 residues but with one exception at 9 residues.
In contrast, in all 23 VH(4) sequences the CDR-H2 only
consisted of 16 residues (7 residues by the IMGT definition)
but VH(3) CDR2 ranged from 16 to 22 residues with a modalFig. 3. Frequency distribution histograms of heavy chain CDR lengths comparing VH(3)
distributions for (a) CDR-H1, (b) CDR-H2, (c) CDR-H3 of the isolated VH(3) (MELG) (n
www.bioinf.org.uk/abs/) for (d) human (n = 277) and mouse (n = 831) and (c) camfrequency of 17 residues (7, 13 and8 residues respectively by the
IMGT definition).
As anticipated, highest variation in length was observed in
the CDR-H3 region, with VH(3) sequences generally displaying
a shorter CDR-H3 length most frequently 12 to 13 residues
(range 3 to 18) compared to IgHV4 sequences. In contrast a
tighter distribution was observed for the VH(4) sequences,
ranging from 11 to 20 amino acids with the highest frequency
of CDR-H3 length observed at 14 and 17 amino acids. These
observations are in broad agreement with a previous analysis
of llama VH(3) and VH(4) sequences, whereby similar
differences in CDR lengths were observed (Deschacht et al.,
2010). These authors proposed that the CDR-H1 and CDR-H2
loops of VH(4) antibodies with 7 and 16 residues respectively,
should adopt the canonical loop structures observed for human
VH(4) domains.
Many studies have reported that an extended CDR-H3
region is a key feature of camelid VHH domains (Muyldermans
et al., 1994; Harmsen et al., 2000; Ghahroudi et al., 1997;
Conrath et al., 2005), so it is pertinent to compare these with
camel VH CDR-H3 lengths observed in this study. Frequency
distributions of the latter are compared in Fig. 3 to camelid
VHH CDR-H3 and also against human and mouse VH CDR-H3
lengths, as extracted from a public database (http://www.
bioinf.org.uk/abs/). It is interesting that all the longer VH(4)and VH(4) familieswith those of camel VHH and human andmouse IgG. Length
= 35) and VH(4) (MRLL) (n = 22) sequences versus published data (http://
el VHH (n = 32) CDR-H3 lengths; CDRs as defined by Kabat et al. (1991).
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43L.M. Grifﬁn et al. / Journal of Immunological Methods 405 (2014) 35–46CDR-H3 sequences fell within the CDR-H3 length range of VHH
antibodies (7 to 24 residues). Only 7 out of 32 of VHH CDR-H3
sequences (22%) had a length greater than the 20 residue limit
of the VH(4) range. In contrast the distribution of CDR-H3
length of camel VH(3) antibodies is similar to that of mouse
IgG. Structural studies have revealed that the VHHdomains can
use their extended CDR-H3 loops to probe clefts on the target
protein surface (Lawson, 2012). This raises the question
whether the preference for longer CDR-H3 lengths may also
enable VH(4) antibodies to probe alternative protein surfaces
compared to VH(3) antibodies.
3.4. Heavy chain constant region sequences
Consistent with the V–D–J-heavy chain recombination
model, the CH1 and hinge regions had high sequence identity
within IgG1a and IgG1b isotypes at 94% or 96% respectively,
irrespective of leader sequence used (Figs. S2 & S4). Differences
were only observed within Bactrian sequences and since only
two individuals from this species were sampled versus 10
dromedaries this seemed surprising. However, the dromedary
genomic database (http://camel.kacst.edu.sa/) indicates a single
CH gamma 1a gene, consistent with the current data, and the
Bactrian genome has been shown to contain six CH1 genes
(Jirimutu et al., 2012) which may along with potential allotypic
variation account for the observed variation. Inter-isotype
comparisons identified seven amino acid differences in the
CH1 region, i.e. 93% consensus sequence identity (Fig. 4). The
camel inter-isotype CH1 region differences are similar in number
to those in human isotypes and less than those between
mouse isotypes. Comparison of the camel CH1 sequences
with human and mouse IgG1 CH1 sequences, deposited in
the ImMunoGeneTics database (www.imgt.org), shows approx-
imately 65% and 63% sequence identity respectively (Fig. 4).
In agreement with Vu et al. (1997) different hinge regions
were utilized for the IgG1a and IgG1b isotypes (Fig. 4). The
IgG1a isotype has a 19 amino acid hinge in contrast to a 12
residue hinge of IgG1b. A conserved C(X)CPKCP motif was
observed at the 3′ end of both hinges, which is analogous to the
motif observed in human hinge regions. Cysteine residues
present in this region have been shown in human antibodies to
be important for the formation of inter-heavy chain disulfide
bonds (Harris et al., 1998).
It is interesting to note that although the observed exception
sequence D75 (Fig. S3) was shown to contain the hallmark VHH
substitutions it retained the characteristics associated with
conventional antibodies, namely a CH1 region and IgG1b hinge
sequence. Converse observations have been made by other
groups, whereby occasionally VH regions lacking a CH1 exon
have been cloned from cDNA (Harmsen and De Haard, 2007;
Saerens et al., 2004). These observations suggest that the
mechanism by which VH genes recombine with IgG1 constant
region genes and VHH genes recombine with IgG2 or IgG3
constant regions genes is not completely specific. Also, since the
two variable region types recombine with shared D and J genes
(Achour et al., 2008), it is currently unclear how this preferential
gene association takes place.Fig. 5. CH2–CH3 region alignment: camel IgG1a versus IgG2 and IgG3 and human
region sequence compared with published (http://www.imgt.org) camel IgG1, hum
Identical residues are displayed as ‘–’‘ and spaces have been introduced for optimaComplete heavy chain constant region sequences (CH2
and CH3) were isolated for both the dromedary and Bactrian
IgG1a isotype (Fig. 5). No inter-species sequence variation
was observed in the CH2 or CH3 domains, exemplifying
the high degree of gene conservation between these two
species. Furthermore a high sequence identity of 95% and
98%, respectively, was observed when compared with the
CH2CH3 region sequences for the camel VHH isotypes, IgG2
and IgG3. Repeated attempts to isolate the CH2 and CH3
region using the IgG1b hinge primer did not yield a 3′ RACE
PCR product probably to inefficient primer design or position-
ing. Only partial IgG1b CH2 sequences were determined from
the heavy chain 5′ RACE PCR reaction: residues 244 to 306.
Consensus sequences for both dromedary and Bactrian IgG1b
isotypeswere identical in this region and differed from IgG1a at
two residues only: A244E and Q281K.
In comparison with the IgG1a camel constant region
sequence, AJ421266 deposited in the ImMunoGeneTics database
(www.imgt.org) there are 7 amino acid substitutions in the CH3
region that are possibly allotypic variants (Fig. 5). Much greater
diversity is seen against human andmouse IgG1 CH2CH3 region,
at 74% and 58% sequence identity, compared to the correspond-
ing camel sequence.
The high sequence similarity across the γ constant regions
of camel species support the hypothesis of Conrath et al. (2003)
who argue convincingly that heavy chain only antibody
constant region genes evolved from IgG1 isotypes relatively
recently, that is after tylopoda species emerged from other
cetartiodactyl lineages. Similarly the convergence of human
and camel clan III variable region genes reported by these
authors and supported by our data must be a relatively recent
evolutionary event.
IgG Fc effector functions have beenmapped at the amino acid
level for human IgG and these residues show a high degree
of conservation with respect to camel CH2CH3 residues, as
indicated by the following residues according to Kabat number-
ing. Thus the complement C1q binding motif (Glu337, Lys339,
Lys341 and Pro350) is identical between these species (Karsten,
2012). N-linked glycosylation is essential both for fully functional
complement and Fc receptor binding and the relevant Asn314
functionally constrained in conformation via hydrogen bonded
Asp278 (Shields et al., 2001) are conserved between species. The
neonatal FcRn bindingmotif (Ile266, Ser257, Lys305Asn, Thr326,
Gln330, Asn465 and His466) and high affinity Fc gamma
receptor (FcγRI) binding motif, also the common binding motif
of all Fc gamma receptors (Leu247, Leu248Pro, Gly249, Gly250,
Pro251, Ala346 and Pro329) each show a single conservative
change between respectively human and camel sequences
(Shields et al., 2001), again suggesting similar across species
function. In the case of the low affinity Fc gamma receptors,
FcγRII and FcγRIII additional 29 and 17 residues respectively
influence Fc binding with the majority sharing cross species
identity. The remainder comprises mainly conservative differ-
ences: thus Arg268Gly, Thr269Arg, Ser280Gly, His281Gln,
His302Arg, Asn303Thr, Arg309Lys, Leu328Gln, and Ala401Asn
for FcγRII and Thr269Arg, Ser280Gly, His281Gln, Tyr313Phe and
Lys353Arg for FcγRIII.and mouse IgG1. Dromedary (n = 4) and Bactrian (n = 1) IgG1a constant
an and mouse IgG1 and the camel IgG2 and IgG3 constant region sequences.
l sequence alignment.
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Previous investigations into camel antibody sequences have
focused upon heavy chain sequence analysis. Minimal infor-
mation is available on the camel light chain, with only a single
lambda light chain protein sequence documented (Conrath et
al., 2005), and a brief discussion of unpublished material
(De Genst et al., 2006). Thus, to investigate light chain sequence
diversity, a light chain RACE campaign was undertaken, in both
the 5′ and 3′ orientations, resulting in isolation of 18 complete
kappa light chain sequences (Fig. S5) and 35 lambda light chain
sequences (Fig. S6). Sequence identity of 58% was observed
when comparing consensus kappa and lambda framework
regions.
For the isolated kappa and lambda sequences, high se-
quence identity was observed in the leader sequence, with
only four kappa and three lambda unique sequences (Figs. S5 &
S6), and since genomic analysis of the dromedary (http://
camel.kacst.edu.sa/) indicates that there are 53 KV and 33 LV
genes this suggests that variable light chain gene usage is
on the low side with a lower limit estimated at 8% and 9%
respectively. In contrast to the heavy chain analysis, both kappa
and lambda light chains showed greatest positional variability
in framework 2 (Fig. 1b). In framework regions 1 and 2 residue
variations could be accounted for almost exclusively by single
base mutations, suggesting a predominance of somatic muta-
tion over V-gene usage. Sequence conservation was greater
in kappa CDRs than in lambda CDRs; respectively for CDR1,
2 & 3 at 35%, 29% and 10% versus 27%, 14% and 0%. The wider
sequence variation observed in the CDR-3 regions, is likely to
be due to the imprecise joining of the V–J genes during gene
recombination.
The phylogenetic analysis of the consensus camel frame-
work sequences (Fig. 2b) showed that the camel kappa variable
region clusters with clan II human IGKV2 and mouse IGKV1
sequences and the camel lambda variable region clusters with
clan I human IGLV1 and IGLV2 sequences. There is 77% identity
between camel and human kappa framework residues and 85%
identity between camel and human lambda framework regions
(Fig. 6), slightly lower values than observed for the equivalent
comparison for heavy chain VH(3) / VH(4) identities (94% and
86%). CDR1 length was consistent at 17 residues for the kappa
chains and at 14 residues in all but one of the lambda chains;
identical to human kappa sub-groups II and IV and lambda
sub-groups I and II respectively (Kabat et al., 1991).
All 18 kappa light chains isolated shared the same constant
region sequence (Fig. 7) suggesting the presence of a single Cκ
gene, in agreement with the unpublished genomic study of De
Genst et al. (2006). In contrast the 35 lambda chains included 10
unique constant region sequences. This is more than the four or
five Cλ gene segments detected by Southern blotting (De Genst
et al., 2006) and the 5 lambda constant region genes revealed by
expressed sequence tag data (Al-Swailem et al., 2010), therefore
the additional number may be explained by the presence of
single residue allotypic variation. Comparison of the camel kappa
light chain constant region with those documented in the IMGT
for human and mouse kappa constant regions, showed 52% and
57% sequence identity respectively. Camel lambda light chain
constant region comparisons with human lambda constant
regions ranged from 78 to 83% sequence identity and mouse
from 60 to 73%.3.6. Heavy and light chain oligonucleotide primers
To aid future work in this field, oligonucleotide primers
designed as a result of this study are detailed in Supplementary
data (Fig. S7). Using this set of primers two rounds of PCRwere
required for isolation of the heavy chain V-region, and three
rounds of PCR for the light chain V-region. When applied to
pooled cDNA isolated from camel B cells, the expected distinct
500 bp band was seen following gel electrophoresis, corre-
sponding to the expected molecular weights for heavy and
light chain variable regions (Fig. S8). In a subsequent study in
our laboratory these oligonucleotides have successfully been
used to isolate the heavy and light chain pairs of conventional
camel antibodies from single B cells to yield functionally active
anti-cytokine Fab′ fragments (L.M.G. neé Hancock, 2011).
3.7. Conclusions
One hundred and fourteen high quality heavy and light
chain camel antibody sequences have been identified: the
previously unpublished complete kappa light chain sequence,
additional lambda light chain sequences, the heavy chain IgG1a
and IgG1b variable region and CH1 domain sequences and the
complete CH2–CH3 constant region sequences for the camel
IgG1a isotype, all serve to add to current sequence knowledge of
conventional camel antibodies. Assessment of the variable and
constant region gene usage between dromedary and Bactrian
camel species has indicated a high level of cross species gene
conservation, implying that comparable H2L2 antibodies can be
isolated fromeither dromedary or Bactrian camels. Furthermore
sequence analysis suggests that camels use the same pattern as
Homo sapiens for VH, D, J and C gene recombination. In both
camelids 40% of isolated heavy chainswere of VH(4) typewith a
MRLL leader sequence and the remainder were of VH(3) type
with aMELG leader sequence. Comparisons of VH(3) and VH(4)
and published VHH sequences have highlighted differences
in the CDR-H3 length of these antibodies: where VH(4) is
intermediate in length between the longer VHH and shorter
VH(3).
Phylogenetic analysis species has revealed a remarkable
similarity between camel and human heavy chain framework
VH(3) and to a lesser extent VH(4) in contrast to the expected
mammalian cladistics observed for the heavy chain constant
region and the light chain framework and constant regions.
This confirms the findings of Vu et al. (1997) on another
camelid species where a similarly close identity was observed
between human and llama VH(3) heavy chain framework
sequences. Development of a therapeutic based on a camelid
VH antibody could thus require mutation of as few as four
residues for a VH(3) region and 12 residues for a lambda light
chain variable region.
Analysis of camel light chain sequences has highlighted
limited germ-line variability in the variable and constant
region light chain genes. This information, together with that
obtained from the isolated VH(3), VH(4) and CH1 sequences,
has enabled primer design for the amplification of camel
heavy and light chain V regions. Primer efficacy has been
demonstrated in this study through recovery of heavy and
light chain cDNA from camel B cells and in subsequent
investigations with the isolation of paired heavy and light
chain sequences of conventional antibodies from individual B
Fig. 6. Alignment of consensus camel light chain variable region sequences compared to corresponding consensus human framework sequences. In the upper
panel the consensus kappa sequence is shown aligned to human IGKV1, IGKV2 and IGKV5 framework consensus sequences, representing clans I, II and III
respectively. In the lower panel the consensus lambda sequence is shown aligned to human IGLV1, IGLV3 and IGLV7 framework consensus sequences,
representing clans I, II and III respectively. Identical residues are displayed as ‘–’.
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enabled functional and structural comparisons to be made
between conventional and VHH antibodies isolated from
individual camelids immunized with a defined antigen. It will
also enable quantitative assessment of the reported optional
requirement (Deschacht et al., 2010) for a light chain in
VH(4) antibodies. Importantly such a structural analysis will
likely reveal how the camelid immune response generatesFig. 7. Alignment of camel kappa and lambda light chain constant region sequences
taken from the IMGT database (http://www.imgt.org). Identical residues are displa
identical for all 18 samples. Ten unique lambda light chain constant region sequenc
29, 40, 43, 48, 50, 60, 62, 66, 70, 71, 72, 74 and 78), 5 had identity with sequence LL3
with LL41 (see Fig. S6).differential VH(3), VH(4) and VHH paratope architecture to
probe flat, convex and concave epitopes on a chosen antigen
(manuscript in preparation).
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